Lastest News From Hemovent GmbH


April 10, 2018

Hemovent starts GLP in vivo trial for long-term use of its
next-gen ExtraCorporeal Membrane Oxygenation (ECMO) system

December 15, 2017

Hemovent appoints Professor Alain Combes, MD, PhD, to its Scientific Advisory Board

October 16, 2017

Hemovent successfully debuts ExtraCorporeal Life Support (ECLS) device from its Artificial Lung platform 

July 20, 2017

Hemovent expands series A financing to fast-forward development of its Artificial Lung platform, including applications for Extracorporeal Life
Support (ECLS) and ExtraCorporeal CO2 Removal (ECCO2R)

June 12, 2017

Hemovent successfully completes first series of in vivo trials of its next-gen ExtraCorporeal Life Support (ECLS) system

April 24, 2017

Hemovent receives government grant to fast-forward development of its next-gen artificial lung technologies

March 22, 2017

Hemovent files two additional patent applications for its portable ECMO device for both circulatory and respiratory support

April 25, 2016

Number of ECMO applications has tripled in five years

February 10, 2016

Hemovent Raises $6 Million in Series A Funding